Clinical Trial: Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment with Anthracyclines And/or Trastuzumab

U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT06881940) titled 'Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment with Anthracyclines And/or Trastuzumab' on March 05.

Brief Summary: This study aims to evaluate the effectiveness of a cardiac rehabilitation protocol, incorporating aerobic and resistance exercise, in reducing the incidence of cardiotoxicity in breast cancer patients receiving treatment with anthracyclines and/or trastuzumab through a randomized, active control group, open-label clinical trial.

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: Cancer Therapy-Related Cardiac Dysfunction

Intervention:...